IC condition | Incidence rate of HZ complications per 100,000 PY (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|
18–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | ≥ 80 | Overall | |
Population | 0.35 (0.18–0.59) | 0.75 (0.53–1.04) | 1.09 (0.81–1.44) | 1.34 (0.99–1.77) | 4.34 (3.63–5.15) | 10.89 (9.6–12.31) | 21.35 (19.08–23.81) | 3.63 (3.39–3.88) |
IC-free cohort | 0.33 (0.17–0.58) | 0.49 (0.3–0.73) | 0.47 (0.29–0.73) | 0.78 (0.51–1.15) | 2.95 (2.33–3.68) | 8.48 (7.25–9.85) | 18.78 (16.49–21.3) | 2.64 (2.42–2.86) |
IC cohort | 0.58 (0.01–3.21) | 5.55 (3.04–9.32) | 9.74 (6.57–13.9) | 6.91 (4.38–10.37) | 14.3 (10.71–18.7) | 24.76 (19.83–30.54) | 36.12 (28.68–44.89) | 14.36 (12.75–16.11) |
HSCT | 310.46 (7.86–1729.79) | 161.25 (4.08–898.45) | 759.63 (305.41–1565.13) | 161.39 (19.55–583) | 232.54 (47.95–679.57) | 0 (0–1492.1) | 0 (0–25,474.82) | 300.77 (164.43–504.63) |
SOT | 0 (0–112.66) | 38.5 (7.94–112.52) | 41.92 (13.61–97.83) | 35.98 (11.68–83.97) | 90.74 (49.61–152.25) | 50.33 (18.47–109.55) | 36.08 (4.37–130.34) | 50.16 (34.94–69.76) |
HN | 4.13 (0.1–23) | 10.68 (2.2–31.22) | 40.77 (20.35–72.95) | 15.49 (4.22–39.65) | 47.43 (25.93–79.58) | 51.98 (29.09–85.73) | 52.86 (25.35–97.22) | 31.8 (24.15–41.11) |
SON | 13.14 (0.33–73.22) | 8 (0.97–28.91) | 9.69 (3.56–21.1) | 6.69 (2.89–13.19) | 11.9 (7.46–18.01) | 22.86 (16.86–30.31) | 36.96 (27.84–48.1) | 18.74 (15.79–22.09) |
NEOPLASIAS | 3.1 (0.08–17.3) | 7.39 (2.01–18.91) | 16.95 (9.49–27.96) | 7.66 (3.82–13.71) | 14.68 (9.97–20.83) | 25.14 (19.14–32.43) | 38.84 (29.91–49.6) | 19.91 (17.15–23) |
HIV | 0 (0–131.63) | 54.1 (19.85–117.76) | 37.1 (16.96–70.43) | 37.36 (10.18–95.65) | 98.64 (20.34–288.25) | 95.01 (2.41–529.36) | 0 (0–1269.77) | 43.2 (27.38–64.82) |
AUTOIMMUNE | 0.71 (0.02–3.96) | 3.15 (1.16–6.86) | 7.91 (4.52–12.84) | 4.25 (1.83–8.37) | 15.32 (10.01–22.45) | 25.27 (17.39–35.48) | 30.81 (19.07–47.09) | 10.18 (8.37–12.26) |
RA | 0 (0–58.05) | 8.28 (0.21–46.11) | 4.5 (0.11–25.08) | 3.15 (0.08–17.56) | 11.08 (3.02–28.37) | 27.05 (12.37–51.36) | 40.7 (17.57–80.2) | 14.87 (9.53–22.12) |
SLE | 0 (0–244.45) | 25.12 (0.64–139.94) | 38.74 (4.69–139.92) | 24.55 (0.62–136.78) | 0 (0–136.77) | 61.59 (1.56–343.18) | 0 (0–461.25) | 25.19 (8.18–58.79) |
IBD | 0 (0–30.57) | 4.17 (0.11–23.23) | 3.84 (0.1–21.39) | 0 (0–18.68) | 18.94 (3.91–55.34) | 15.59 (1.89–56.3) | 29.53 (3.58–106.69) | 7.67 (3.51–14.57) |
PSORIASIS | 0 (0–3.86) | 0 (0–3.42) | 0.99 (0.03–5.52) | 2.27 (0.27–8.19) | 6.63 (2.15–15.48) | 7.88 (2.15–20.17) | 35.83 (15.47–70.6) | 3.7 (2.26–5.71) |
MS | 0 (0–220.87) | 0 (0–71.54) | 0 (0–59.58) | 0 (0–85.36) | 38.62 (0.98–215.15) | 0 (0–344.05) | 0 (0–1436.88) | 4.7 (0.12–26.21) |
AT | 0 (0–123.35) | 15.73 (0.4–87.64) | 0 (0–47.47) | 0 (0–46.07) | 0 (0–64.98) | 0 (0–117.91) | 0 (0–322.51) | 2.85 (0.07–15.89) |